- Home
- FBLA vs ITOS Comparison
FBLA vs ITOS Comparison
Compare FBLA & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBLA
- ITOS
- Stock Information
- Founded
- FBLA 1908
- ITOS 2011
- Country
- FBLA United States
- ITOS United States
- Employees
- FBLA N/A
- ITOS N/A
- Industry
- FBLA
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FBLA
- ITOS Health Care
- Exchange
- FBLA NYSE
- ITOS Nasdaq
- Market Cap
- FBLA 226.5M
- ITOS 270.7M
- IPO Year
- FBLA N/A
- ITOS 2020
- Fundamental
- Price
- FBLA $10.84
- ITOS $9.99
- Analyst Decision
- FBLA
- ITOS Hold
- Analyst Count
- FBLA 0
- ITOS 6
- Target Price
- FBLA N/A
- ITOS $10.60
- AVG Volume (30 Days)
- FBLA 84.3K
- ITOS 1.8M
- Earning Date
- FBLA 05-12-2025
- ITOS 08-07-2025
- Dividend Yield
- FBLA N/A
- ITOS N/A
- EPS Growth
- FBLA N/A
- ITOS N/A
- EPS
- FBLA N/A
- ITOS N/A
- Revenue
- FBLA $66,405,000.00
- ITOS $35,000,000.00
- Revenue This Year
- FBLA N/A
- ITOS N/A
- Revenue Next Year
- FBLA N/A
- ITOS N/A
- P/E Ratio
- FBLA N/A
- ITOS N/A
- Revenue Growth
- FBLA N/A
- ITOS 177.89
- 52 Week Low
- FBLA $9.81
- ITOS $4.80
- 52 Week High
- FBLA $12.74
- ITOS $18.13
- Technical
- Relative Strength Index (RSI)
- FBLA N/A
- ITOS 65.96
- Support Level
- FBLA N/A
- ITOS $9.93
- Resistance Level
- FBLA N/A
- ITOS $10.21
- Average True Range (ATR)
- FBLA 0.00
- ITOS 0.18
- MACD
- FBLA 0.00
- ITOS -0.11
- Stochastic Oscillator
- FBLA 0.00
- ITOS 18.07
About FBLA FB BANCORP INC
FB Bancorp Inc is a holding company. The company operates through its subsidiary Fidelity Bank. Fidelity business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market areas. The services of the company also include residential construction loans, commercial real estate loans (which includes commercial mortgage, commercial construction and land development loans), commercial loans (which includes commercial and industrial, small business and other commercial loans not secured by real estate), home equity loans and lines of credit, and consumer loans.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.